Your browser doesn't support javascript.
loading
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Seagle, Brandon-Luke L; Eng, Kevin H; Dandapani, Monica; Yeh, Judy Y; Odunsi, Kunle; Shahabi, Shohreh.
Afiliação
  • Seagle BL; Department of Obstetrics, Gynecology and Reproductive Sciences, Western Connecticut Health Network, Danbury, CT, USA.
  • Eng KH; Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Dandapani M; Department of Obstetrics, Gynecology and Reproductive Sciences, Western Connecticut Health Network, Danbury, CT, USA.
  • Yeh JY; Department of Obstetrics, Gynecology and Reproductive Sciences, Western Connecticut Health Network, Danbury, CT, USA.
  • Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Shahabi S; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Prentice Women's Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Oncotarget ; 6(21): 18641-52, 2015 Jul 30.
Article em En | MEDLINE | ID: mdl-26215675

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína Supressora de Tumor p53 / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína Supressora de Tumor p53 / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article